
Veriskin is a medical device and technology company focused on revolutionizing skin cancer screening. Their flagship product, the TruScore device, is a non-invasive, handheld tool designed to assist non-specialist caregivers in rapidly and objectively determining if a suspect skin lesion is cancerous. The device offers real-time, dynamic measurements of cutaneous hemodynamics, providing objective and accurate assessments. Key features include ease of use, non-invasiveness, real-time data, and a compact, durable design with a long battery life. Veriskin's proprietary AI technology, combined with high-precision components, ensures fast and accurate results in just two minutes, aiming to improve front-line diagnosis and reduce false positives and unnecessary referrals, ultimately saving lives through early detection.

Veriskin is a medical device and technology company focused on revolutionizing skin cancer screening. Their flagship product, the TruScore device, is a non-invasive, handheld tool designed to assist non-specialist caregivers in rapidly and objectively determining if a suspect skin lesion is cancerous. The device offers real-time, dynamic measurements of cutaneous hemodynamics, providing objective and accurate assessments. Key features include ease of use, non-invasiveness, real-time data, and a compact, durable design with a long battery life. Veriskin's proprietary AI technology, combined with high-precision components, ensures fast and accurate results in just two minutes, aiming to improve front-line diagnosis and reduce false positives and unnecessary referrals, ultimately saving lives through early detection.